They are funded through until at least mid next year by which time they will have results of three phase 2 trials. The most important milestone this year is the interim data release for SNT 5505 in myelofibrosis - and a presentation at ASH in December. Spec buy and hold until then in my opinion.
- Forums
- ASX - By Stock
- SNT
- Ann: Phase 2 Trial Reaches 50% Recruitment
Ann: Phase 2 Trial Reaches 50% Recruitment, page-5
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SNT (ASX) to my watchlist
|
|||||
Last
4.0¢ |
Change
-0.006(13.0%) |
Mkt cap ! $47.76M |
Open | High | Low | Value | Volume |
4.7¢ | 4.7¢ | 3.9¢ | $132.3K | 3.180M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 81755 | 4.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.1¢ | 39862 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 488 | 0.041 |
10 | 204553 | 0.040 |
6 | 523840 | 0.039 |
3 | 430000 | 0.038 |
2 | 113800 | 0.037 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 125000 | 1 |
0.040 | 8000 | 1 |
0.041 | 210312 | 2 |
0.042 | 10000 | 1 |
0.043 | 50000 | 1 |
Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
Featured News
SNT (ASX) Chart |